Iveda announces a public offering of shares and warrants, aiming to raise approximately $2 million for corporate purposes.
Quiver AI Summary
Iveda® (Nasdaq: IVDA) has announced a public offering of 5,714,286 shares of its common stock, along with series X warrants for the purchase of an additional 11,428,572 shares, all priced at $0.35 each. The exercise price for the series X warrants will also be $0.35, valid for two years from issuance. The offering is expected to close on or about February 11, 2026, and is anticipated to generate approximately $2 million in gross proceeds, which will be used for various corporate purposes including research, debt repayment, and working capital. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, and a registration statement has been filed with the SEC. The release includes forward-looking statements and cautions investors to consider associated risks.
Potential Positives
- The company is raising approximately $2.0 million through the public offering, providing significant capital for various corporate purposes.
- Funds from the offering are intended for research and development, which could enhance Iveda's product offerings and market competitiveness.
- The exercise price of the series X warrants is set at $0.35 per share, creating an incentive for investors that could lead to increased shareholder engagement.
Potential Negatives
- The company is raising funds through a public offering at a low price of $0.35 per share, which may indicate challenges in perceived value and confidence in its stock.
- The gross proceeds of approximately $2.0 million might suggest financial struggles, particularly as the funds are intended for general corporate purposes rather than a specific growth strategy.
- The issuance of warrants along with the shares may dilute existing shareholders' ownership and value in the company, leading to potential investor dissatisfaction.
FAQ
What is the purpose of Iveda's public offering?
The public offering will support general corporate purposes, including R&D, debt repayment, and capital expenditures.
How many shares are being offered in the Iveda public offering?
Iveda is offering 5,714,286 shares of its common stock, along with series X warrants.
What is the price per share for this offering?
The combined public offering price is $0.35 per share or pre-funded warrant.
Who is managing Iveda's public offering?
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
When is the closing date for the offering?
The closing is expected to occur on or about February 11, 2026, subject to customary conditions.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$IVDA Hedge Fund Activity
We have seen 7 institutional investors add shares of $IVDA stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRW SECURITIES, LLC added 116,269 shares (+inf%) to their portfolio in Q3 2025, for an estimated $155,800
- VANGUARD GROUP INC added 46,665 shares (+129.0%) to their portfolio in Q4 2025, for an estimated $39,198
- LEE FINANCIAL CO removed 30,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $25,200
- GEODE CAPITAL MANAGEMENT, LLC added 18,904 shares (+58.7%) to their portfolio in Q4 2025, for an estimated $15,879
- XTX TOPCO LTD removed 10,984 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $14,718
- TOWER RESEARCH CAPITAL LLC (TRC) added 2,347 shares (+111.0%) to their portfolio in Q3 2025, for an estimated $3,144
- RAYMOND JAMES FINANCIAL INC removed 444 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $594
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
MESA, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Iveda ® (Nasdaq: IVDA), the global leader in AI video surveillance and smart city solutions, today announced the pricing of a public offering of 5,714,286 shares of its common stock (or pre-funded warrants in lieu thereof) and series X warrants to purchase up to 11,428,572 shares of its common stock, at a combined public offering price of $0.35 per share (or pre-funded warrant in lieu thereof) and accompanying series X warrants. The series X warrants will have an exercise price of $0.35 per share, will be exercisable immediately upon issuance and will expire two years from the date of issuance. The closing of the offering is expected to occur on or about February 11, 2026, subject to the satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The gross proceeds to the Company from the offering are expected to be approximately $2.0 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for general corporate purposes, which may include research and development, repayment of existing indebtedness, working capital, capital expenditures, acquisitions, joint ventures and stock repurchase programs.
A registration statement on Form S-1 (File No. 333-293126) relating to the public offering was declared effective by the Securities and Exchange Commission (the “SEC”) on February 9, 2026. The public offering is being made only by means of a prospectus forming part of the effective registration statement relating to the public offering. A preliminary prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC’s website at http://www.sec.gov and may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at [email protected] .
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About Iveda Solutions ®
Iveda (NASDAQ: IVDA) is the provider of global solutions for cloud-based, video AI search and surveillance technologies that protect the people, places, and things that matter the most. Iveda’s technology provides instant intelligence to existing infrastructure, enabling cities and organizations around the world to seamlessly enter the fifth industrial revolution. Headquartered in Mesa, Arizona, with a subsidiary in Taiwan, Iveda is publicly traded under the ticker symbol “IVDA.”
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws, including, without limitation, statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering. These statements are based on current expectations as of the date of this press release and involve risks and uncertainties that may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. We encourage readers to review the “Risk Factors” in the prospectus included in our registration statement on Form S-1 for a comprehensive understanding. Iveda undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release, except as required by applicable laws or regulations.
Media Contact
Olivia Civiletto Erwin
[email protected]
716.785.1108